2023 - Research.com Medicine in Canada Leader Award
2023 - Research.com Genetics in Canada Leader Award
The scientist’s investigation covers issues in Genetics, Allele, Internal medicine, Psychiatry and Schizophrenia. His study in Haplotype, Transmission disequilibrium test, Gene, Linkage disequilibrium and Genome-wide association study is carried out as part of his Genetics studies. His Allele research incorporates elements of Locus and Genotype.
In his study, Clozapine and Receptor is strongly linked to Endocrinology, which falls under the umbrella field of Internal medicine. His Psychiatry research is multidisciplinary, incorporating perspectives in Overeating, Dopamine receptor D2 and Clinical psychology. His work deals with themes such as Bipolar disorder, Genetic heterogeneity, Psychosis and Pharmacogenetics, which intersect with Schizophrenia.
Genetics, Internal medicine, Schizophrenia, Psychiatry and Endocrinology are his primary areas of study. His Genetics study often links to related topics such as Psychosis. His biological study spans a wide range of topics, including Genetic determinism and Genetic linkage.
His research integrates issues of Bipolar disorder, Polymorphism, Neuroscience and Oncology in his study of Internal medicine. His studies in Schizophrenia integrate themes in fields like Pharmacogenetics and Pharmacology. James L. Kennedy has researched Allele in several fields, including Attention deficit hyperactivity disorder, Genotype and Candidate gene.
His primary scientific interests are in Internal medicine, Schizophrenia, Pharmacogenetics, Genome-wide association study and Clinical psychology. His Internal medicine research incorporates themes from Antidepressant, Endocrinology, Depression, Late life depression and Oncology. James L. Kennedy has included themes like Genetics, Gene, Single-nucleotide polymorphism and Pharmacology in his Schizophrenia study.
His work in Candidate gene and Allele is related to Genetics. His Pharmacogenetics study also includes fields such as
James L. Kennedy focuses on Schizophrenia, Pharmacogenetics, Clinical psychology, Internal medicine and Major depressive disorder. His work carried out in the field of Schizophrenia brings together such families of science as Psychosis, Genome-wide association study and Weight change. His Genome-wide association study research includes elements of Bipolar disorder, Genetic association and Genetic architecture.
Pharmacogenetics is a primary field of his research addressed under Genetics. A large part of his Genetics studies is devoted to Exome sequencing. His Internal medicine research integrates issues from CYP2C19, Endocrinology, Mitochondrion and Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Aiden Corvin;James T. R. Walters.
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
S. Hong Lee;Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Stephen V. Faraone.
Nature Genetics (2013)
STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation.
P Gallagher;C Ryan;S Byrne;Julia Kennedy.
principles and practice of constraint programming (2008)
West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials
J Shepherd;SM Cobbe;AR Lorimer;JH McKillop.
The Lancet (1996)
Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4
Pamela Sklar;Pamela Sklar;Stephan Ripke;Stephan Ripke;Laura J. Scott;Ole A. Andreassen.
Nature Genetics (2011)
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.
Xian-Zhang Hu;Robert H. Lipsky;Guanshan Zhu;Longina A. Akhtar.
American Journal of Human Genetics (2006)
Multiple dopamine D4 receptor variants in the human population
Van Tol Hh;Wu Cm;Guan Hc;Ohara K.
Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder.
LaHoste Gj;Swanson Jm;Wigal Sb;Glabe C.
Molecular Psychiatry (1996)
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores
Bjarni J. Vilhjálmsson;Jian Yang;Hilary K. Finucane;Alexander Gusev.
American Journal of Human Genetics (2015)
A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11
Brian F. O'Dowd;Michael Heiber;Audrey Chan;Henry H.Q. Heng.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: